Dare Bioscience, Inc.
DARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401914
No open-market purchases or sales by Dare Bioscience, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.75M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Dare Bioscience, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 29 | 28 | −1 |
| Shares | 6.89M | 6.51M | −380.9K (−5.5%) |
| Value | $7.16M | $5.92M | −$1.24M (−17.3%) |
New holders (4)
Institutions that held Dare Bioscience, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 164,021 | $149.3K | 0.00% |
| FMR LLC | 250 | $228 | 0.00% |
| Caldwell Sutter Capital, Inc. | 200 | $182 | 0.00% |
| Royal Bank of Canada | 382 | $0 | 0.00% |
Sold out (5)
Institutions that held Dare Bioscience, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Soviero Asset Management, LP | 130,000 | $135.2K |
| Jane Street Group, LLC | 75,342 | $78.4K |
| Virtu Financial LLC | 32,481 | $34.0K |
| Beacon Pointe Advisors, LLC | 11,200 | $11.6K |
| JPMorgan Chase & Co | 9,358 | $10.0K |